Top Ai Drug Discovery Companies in China

The company emphasizes its deep expertise in applied artificial intelligence (AI) and drug discovery, highlighting its potential to revolutionize the new drug discovery process.

Viva Biotech specializes in Structure-Based Drug Discovery (SBDD), offering comprehensive services that support the entire drug development process from early-stage research to commercial manufacturing. Their innovative technology platform and expert team enhance the R&D capabilities for global biotechnology and pharmaceutical companies, making them a valuable partner in the pursuit of innovative drug development.

The company is actively developing an AI-based drug discovery system that includes tools for predicting drug efficacy, screening compounds, and optimizing lead molecules. Their use of deep learning enhances the understanding of chemical interactions and properties, ultimately aiming to streamline the development of safe and effective clinical candidates.

MindRank is a clinical-stage AI-powered drug discovery company that specializes in developing innovative therapeutics, including a promising allosteric inhibitor. With a team of over 40 scientists and collaborations with biopharma, MindRank focuses on AI-enabled approaches to tackle challenging molecular targets.

SciCalQ specializes in AI solutions and computational chemistry, specifically aimed at enhancing the drug discovery process. With a focus on artificial intelligence applications, they offer services such as physical property predictions and molecular dynamics simulations to accelerate the development of new drugs.

Adagene is a clinical-stage immunotherapy company that is redefining the discovery and design of therapeutic antibodies through its innovative platform and unique antibody technologies. Their precision engineering approach allows them to identify and select antibody candidates that can effectively target cancer, making their work highly relevant to the field of AI drug discovery.

LeadArt, a pioneering biotechnology company in China, is utilizing advanced chemical proteomics and automation technologies to enhance drug discovery. The company is focused on expanding the drug target space and has developed a comprehensive live cell target-probe database.

WuXi Biology specializes in advancing drug discovery through a comprehensive platform that integrates target identification, hit validation, and preclinical development. Their expertise spans various therapeutic modalities and disease areas, making them a valuable partner for accelerating the journey from target discovery to candidate selection.

BioDuro-Sundia is a prominent contract research, development, and manufacturing organization (CRDMO) with over 28 years of experience, specializing in small and large molecule drug discovery and development. They offer fully integrated services from target identification to commercial drug product manufacturing, leveraging unique technology platforms to support biotech and pharmaceutical partners worldwide.

Sanyou Biopharmaceuticals Co., Ltd. has established an integrated innovative biologic drug R&D laboratory and developed industry-leading technology platforms that enhance the discovery and optimization of biologic drugs. Their mission is to simplify the R&D process for innovative biologics, which aligns with advancements in AI-driven drug discovery.